Hologram QSAR studies on farnesoid X receptor activators

被引：20

作者：

Honorio, Kathia M. ^{[1
]}

Garratt, Richard C. ^{[1
]}

Polikarpov, Igor ^{[1
]}

Andricopulo, Adriano D. ^{[1
]}

机构：

[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil

来源：

LETTERS IN DRUG DESIGN & DISCOVERY | 2006年 / 3卷 / 04期

关键词：

hQSAR; drug design; FXR; medicinal chemistry; cholesterol;

D O I：

10.2174/157018006776743206

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Farsenoid X receptor (FXR) is an attractive drug target due to its role in the regulation of cholesterol and bile acid levels' Hologram quantitative structure-activity relationships (HQSAR) were conducted on a series of FXR activators, and the final model obtained was used to predict the potency of 10 test set compounds. The predicted values were in good agreement with the experimental results.

引用

页码：261 / 267

页数：7

共 16 条

[1] Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors [J].

Castilho, MS ;

Postigo, MP ;

de Paula, CBV ;

Montanari, CA ;

Oliva, G ;

Andricopulo, AD .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (02) :516-527

[2] Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms [J].

Chiang, JYL .

JOURNAL OF HEPATOLOGY, 2004, 40 (03) :539-551

[3] Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation [J].

Fujino, T ;

Une, M ;

Imanaka, T ;

Inoue, K ;

Nishimaki-Mogami, T .

JOURNAL OF LIPID RESEARCH, 2004, 45 (01) :132-138

[4] Principles for modulation of the nuclear receptor superfamily [J].

Gronemeyer, H ;

Gustafsson, JÅ ;

Laudet, V .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) :950-964

[5] Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators [J].

Honorio, KM ;

Garratt, RC ;

Andricopulo, AD .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) :3119-3125

[6] The farnesoid X receptor (FXR) as modulator of bile acid metabolism [J].

Kuipers, F ;

Claudel, T ;

Sturm, E ;

Staels, B .

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (04) :319-326

[7] Identification of a chemical tool for the orphan nuclear receptor FXR [J].

Maloney, PR ;

Parks, DJ ;

Haffner, CD ;

Fivush, AM ;

Chandra, G ;

Plunket, KD ;

Creech, KL ;

Moore, LB ;

Wilson, JG ;

Lewis, MC ;

Jones, SA ;

Willson, TM .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (16) :2971-2974

[8] Structural basis for bile acid binding and activation of the nuclear receptor FXR [J].

Mi, LZ ;

Devarakonda, S ;

Harp, JM ;

Han, C ;

Pellicciari, R ;

Willson, TM ;

Khorasanizadeh, S ;

Rastinejad, F .

MOLECULAR CELL, 2003, 11 (04) :1093-1100

[9] Discovery of novel nuclear receotor modulating ligands: an for peptide interaction integral role profiling [J].

Pearce, KH ;

Iannone, MA ;

Simmons, CA ;

Gray, JG .

DRUG DISCOVERY TODAY, 2004, 9 (17) :741-751

[10] Farnesoid X receptor: From structure to potential clinical applications [J].

Pellicciari, R ;

Costantino, G ;

Fiorucci, S .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5383-5403

← 1 2 →